Differential effects of eicosapentaenoic acid and docosahexaenoic acid in promoting the differentiation of 3T3-L1 preadipocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 1, 2014, Pages 13-21

  Murali, Ganesan ^a,b,c   Desouza, Cyrus V ^a,c   Clevenger, Michelle E ^a,c   Ramalingam, Ramesh ^a,c   Saraswathi, Viswanathan ^a,b,c  

^a 983020 University of Nebraska Medical Center   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Adipogenesis; DHA; Docosapentaenoic acid; EPA; N 3 fatty acids

Indexed keywords

ADIPONECTIN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; FATTY ACID ANALYSIS; INHIBITION KINETICS; LIPID COMPOSITION; LIPID STORAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; SIGNAL TRANSDUCTION;

ADIPOGENESIS; DHA; DOCOSAPENTAENOIC ACID; EPA; N-3 FATTY ACIDS;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; MICE;

EID: 84891153713     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.10.002     Document Type: Article

References (56)

1. Bluher M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 2009, 117:241-250.
2. Ebbert J.O., Jensen M.D. Fat depots, free fatty acids, and dyslipidemia. Nutrients 2013, 5:498-508.
3. Verna E.C., Berk P.D. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin. Liver Dis. 2008, 28:407-426.
4. Capurso C., Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul. Pharmacol. 2012, 57:91-97.
5. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
6. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
7. Puglisi M.J., Hasty A.H., Saraswathi V. The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J. Nutr. Biochem. 2011, 22:101-108.
8. Saraswathi V., Gao L., Morrow J.D., Chait A., Niswender K.D., Hasty A.H. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J. Nutr. 2007, 137:1776-1782.
9. Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 2005, 54:412-423.
10. Manickam E., Sinclair A.J., Cameron-Smith D. Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes. Lipids Health Dis. 2010, 9:57.
11. Hanada H., Morikawa K., Hirota K., Nonaka M., Umehara Y. Induction of apoptosis and lipogenesis in human preadipocyte cell line by n-3 PUFAs. Cell Biol. Int. 2011, 35:51-59.
12. Tanabe Y., Matsunaga Y., Saito M., Nakayama K. Involvement of cyclooxygenase-2 in synergistic effect of cyclic stretching and eicosapentaenoic acid on adipocyte differentiation. J. Pharmacol. Sci. 2008, 106:478-484.
13. Kim H.K., Della-Fera M., Lin J., Baile C.A. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr 2006, 136:2965-2969.
14. Weber C., Erl W., Pietsch A., Danesch U., Weber P.C. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc. Biol. 1995, 15:622-628.
15. Kishida E., Tajiri M., Masuzawa Y. Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor. Biochim. Biophys. Acta 2006, 1761:454-462.
16. Mickleborough T.D., Tecklenburg S.L., Montgomery G.S., Lindley M.R. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin. Nutr. 2009, 28:71-77.
17. Carpentier Y.A., Portois L., Malaisse W.J. n-3 fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 2006, 83:1499S-1504S.
18. Mozaffarian D., Wu J.H. (n-3) Fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?. J. Nutr. 2012, 142:614S-625S.
19. Saraswathi V., Hasty A.H. Inhibition of long-chain acyl coenzyme A synthetases during fatty acid loading induces lipotoxicity in macrophages. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1937-1943.
20. Fei Z., Bera T.K., Liu X., Xiang L., Pastan I. Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts. J. Biol. Chem. 2011, 286:27761-27768.
21. M. Ganesan, G.L. Milne, C.D. Webb, A.B. Stewart, R.P. McMillan, B.C. Lyle, M.W. Hulver, V. Saraswathi, Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR-/-Mice, J. Lipid Res., (2012).
22. Saraswathi V., Hasty A.H. The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J. Lipid Res. 2006, 47:1406-1415.
23. Folch J., Lees M., Stanley G.H.Sloane A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
24. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 1964, 5:600-608.
25. Ma D.W., Seo J., Switzer K.C., Fan Y.Y., McMurray D.N., Lupton J.R., Chapkin R.S. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J. Nutr. Biochem. 2004, 15:700-706.
26. Kim K.A., Kim J.H., Wang Y., Sul H.S. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol. Cell Biol. 2007, 27:2294-2308.
27. Tanabe Y., Koga M., Saito M., Matsunaga Y., Nakayama K. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J. Cell Sci. 2004, 117:3605-3614.
28. Ling H.Y., Wen G.B., Feng S.D., Tuo Q.H., Ou H.S., Yao C.H., Zhu B.Y., Gao Z.P., Zhang L., Liao D.F. MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin. Exp. Pharmacol. Physiol. 2011, 38:239-246.
29. Schroder K., Wandzioch K., Helmcke I., Brandes R.P. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 2009, 29:239-245.
30. Prusty D., Park B.H., Davis K.E., Farmer S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 2002, 277:46226-46232.
31. Bost F., Caron L., Marchetti I., Dani C., Le Marchand-Brustel Y., Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 2002, 361:621-627.
32. Bost F., Aouadi M., Caron L., Binetruy B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005, 87:51-56.
33. Todoric J., Loffler M., Huber J., Bilban M., Reimers M., Kadl A., Zeyda M., Waldhausl W., Stulnig T.M. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 2006, 49:2109-2119.
34. Oster R.T., Tishinsky J.M., Yuan Z., Robinson L.E. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl. Physiol. Nutr. Metab. 2010, 35:783-789.
35. Tishinsky J.M., Ma D.W., Robinson L.E. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes. Obesity (Silver Spring) 2011, 19:262-268.
36. Kalupahana N.S., Claycombe K., Newman S.J., Stewart T., Siriwardhana N., Matthan N., Lichtenstein A.H., Moustaid-Moussa N. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J. Nutr. 2010, 140:1915-1922.
37. Brown E.R., Subbaiah P.V. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts. Lipids 1994, 29:825-829.
38. Hashimoto M., Hossain S., Yamasaki H., Yazawa K., Masumura S. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 1999, 34:1297-1304.
39. Hashimoto M., Hossain S., Shido O. Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity. Mol. Cell Biochem. 2006, 293:1-8.
40. von Schacky C., Weber P.C. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 1985, 76:2446-2450.
41. Gronn M., Christensen E., Hagve T.A., Christophersen B.O. Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells. Biochim. Biophys. Acta 1991, 1081:85-91.
42. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71:1085-1094.
43. Mori T.A., Woodman R.J., Burke V., Puddey I.B., Croft K.D., Beilin L.J. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radical Biol. Med. 2003, 35:772-781.
44. Iwami D., Nonomura K., Shirasugi N., Niimi M. Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells. Int. Immunopharmacol. 2011, 11:384-389.
45. Kawashima A., Harada T., Imada K., Yano T., Mizuguchi K. Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:59-65.
46. Yamamoto K., Itoh T., Abe D., Shimizu M., Kanda T., Koyama T., Nishikawa M., Tamai T., Ooizumi H., Yamada S. Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents. Bioorg. Med. Chem. Lett. 2005, 15:517-522.
47. Itoh T., Yamamoto K. Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand. Naunyn Schmiedebergs Arch. Pharmacol. 2008, 377:541-547.
48. Gotoh C., Hong Y.H., Iga T., Hishikawa D., Suzuki Y., Song S.H., Choi K.C., Adachi T., Hirasawa A., Tsujimoto G., Sasaki S., Roh S.G. The regulation of adipogenesis through GPR120. Biochem. Biophys. Res. Commun. 2007, 354:591-597.
49. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
50. Anderson B.M., Ma D.W. Are all n-3 polyunsaturated fatty acids created equal?. Lipids Health Dis. 2009, 8:33.
51. Buckley R., Shewring B., Turner R., Yaqoob P., Minihane A.M. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br. J. Nutr. 2004, 92:477-483.
52. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., Beilin L.J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000, 102:1264-1269.
53. Wei M.Y., Jacobson T.A. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr. Atheroscler. Rep. 2011, 13:474-483.
54. Raclot T., Groscolas R., Langin D., Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J. Lipid Res. 1997, 38:1963-1972.
55. Yu Y., Wu Y., Patch C., Wu Z., Szabo A., Li D., Huang X.F. DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet. J. Nutr. Biochem. 2013, 24:1349-1358.
56. Poudyal H., Panchal S.K., Ward L.C., Brown L. Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J. Nutr. Biochem. 2013, 24:1041-1052.